ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1026

Psoriatic Arthritis and Spondyloarthritis: Inflammation Assessed by “Head to Toe” Wholebody Magnetic Resonance Imaging – A Comparison with Clinical Joint Examination

René Panduro Poggenborg1, Susanne Juhl Pedersen2, Iris Eshed3, Inge Juul Sørensen4, Ole Rintek Madsen5, J.M. Møller6 and Mikkel Østergaard7, 1Department of Rheumatology, Copenhagen University Hospital in Glostrup, Copenhagen, Denmark, 2Dept. of Rheumatology, Copenhagen Center for Arthritis Research, Copenhagen, Denmark, 3Department of Radiology, Sheba Medical Center, Tel Hashomer, Israel, 4Department of Rheumatology, Glostrup Hospital, Copenhagen, Denmark, 5Department of Rheumatology, Copenhagen University Hospital in Gentofte, Copenhagen, Denmark, 6Department of Radiology, Copenhagen University Hospital in Herlev, Copenhagen, Denmark, 7Copenhagen University Hospital Glostrup, Glostrup, Denmark

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Magnetic resonance imaging (MRI), psoriatic arthritis and spondylarthropathy

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Imaging of Rheumatic Diseases: Magnetic Resonance Imaging, Computed Tomography and X-ray

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Psoriatic arthritis (PsA) and spondyloarthritis (SpA) is associated with a varied pattern of axial and peripheral inflammation. Wholebody magnetic resonance imaging (WBMRI) is a new imaging modality where patients are scanned from head to toe in one single examination. The purpose was to explore the potential of WBMRI for detecting peripheral and axial inflammation.

Methods:

Patients with clinically active peripheral PsA (Moll and Wright, n=19) or axial SpA (ESSG, n=19) and healthy subjects (HS, n=12) were included. T1-weighted pre/post-contrast and STIR sequences were performed on a 3 tesla MRI unit. Synovitis and bone marrow oedema (BME) were evaluated at sites included in the 78-tender joint count (TJC). Axially, BME was evaluated dichotomously in each discovertebral unit (DVU) of the spine, and in each quadrant of the sacroiliac joints (SIJ).

Results:

Characteristics median (range): PsA/SpA/HS age 49(23-79)/42(26-61)/32(20-61) yrs. PsA/SpA disease duration: 4 (0-34)/17 (5-48) yrs; 78-TJC: 11(3-65)/3(0-17), 76-swollen joint count (SJC): 5(0-20)/1(0-5), and BASDAI score 45(9-85)/55(2-93) mm.

WBMRI assessment was done in 3800 joints included in the TJC, and synovitis/BME were detected in 593 (16%)/207 (5%) joints, synovitis/BME was absent in 1929 (51%)/1860 (49%) joints, and 1278 (34%)/1733 (54%) joints were not possible to evaluate. Evaluation was most frequently possible in the hip joints (188 joints (94%)), knees (186 (93%)), and the spine (in overall 94% of DVUs). In contrast, no temperomandibular joints, and only 17 (8%) of elbows could be evaluated.

In PsA, synovitis was found most frequently in carpometacarpal (CMC) (19 joints (61%)) and shoulder (18 (53%)) joints. In SpA, synovitis was found most frequently in 1st metatarsophalangeal joints (21 (67%)), and shoulders (17 (50%)).

In patients, the best agreement between WBMRI synovitis and clinical swelling was found at the right hand proximal interphalangeal (PIP) (kappa: 0.65), left hand 3rd distal interphalangeal joint (0.63), and the right hand 3rd PIP joints (0.62). The best agreement between WBMRI synovitis and tenderness was found at left foot 2nd and 3rd PIP (0.78; 0.47), and right hand 2nd PIP (0.70) joints.

In PsA, we found a significant correlation between SJC-28 and BME assessed in 28 and 78 joints (Spearman’s rho: 0.54, P<0.05; 0.69, P<0.005). WBMRI synovitis did not correlate significantly with clinical joint examination. Scores of BME assessed in 78 joints were significantly higher in PsA/SpA compared to HS (Mann-Whitney, P<0.05).

BME in the spine was detected in PsA/SpA in median 2 (0-6)/1 (0-11) DVU, respectively, and BME in the SIJ was detected in 0 (0-2)/0 (0-8) quadrants, respectively. Sum scores of BME detected in spine and SIJ were for PsA: 2 (0-7) and SpA: 4 (0-11), which were significantly higher than in HS (1 (0-4)) (P<0.05).

Conclusion:

Wholebody MRI scores of axial and peripheral bone marrow oedema are significantly higher in clinically active PsA and SpA patients than in healthy subjects. In PsA, we found a significant correlation between number of joints with BME and SJC, whereas TJC did not correlate. WBMRI is a promising imaging modality, as it allows simultaneous visualisation of inflammation in peripheral and axial joints.


Disclosure:

R. P. Poggenborg,
None;

S. J. Pedersen,
None;

I. Eshed,
None;

I. J. Sørensen,
None;

O. R. Madsen,
None;

J. M. Møller,
None;

M. Østergaard,

Abbott Laboratories, Amgen, Bristol-Meyers Squibb, Centocor, Genmab, Glaxo-Smith-Kline, Janssen, Merck, Mundipharma, Novartis, Novo, Pfizer, Roche, Schering-Plough, UCB, Wyeth,

2.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/psoriatic-arthritis-and-spondyloarthritis-inflammation-assessed-by-head-to-toe-wholebody-magnetic-resonance-imaging-a-comparison-with-clinical-joint-examination/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology